BLLN
BillionToOne·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BLLN Profile
Billiontoone, Inc.
A high-growth U.S.molecular diagnostics company,specializing in single-base-pair precision DNA detection technology,primarily focused on non-invasive prenatal testing and cancer liquid biopsy products
1035 O’Brien Drive
Menlo Park
CA 94025
--
BillionToOne, Inc., began operations as a Delaware corporation in 2016. The company has developed a revolutionary single-molecule NGS platform capable of detecting and precisely quantifying gene targets with single-molecule sensitivity. The company's technology platform enables it to create industry-leading prenatal and oncology products.
